Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1961 1
1963 1
1964 2
1965 1
1967 1
1969 2
1970 2
1971 1
1972 7
1973 3
1974 4
1975 3
1976 4
1977 5
1978 7
1979 2
1980 4
1981 8
1982 4
1983 2
1984 5
1985 1
1986 8
1987 19
1988 9
1989 15
1990 11
1991 16
1992 25
1993 36
1994 30
1995 39
1996 49
1997 58
1998 75
1999 92
2000 100
2001 117
2002 142
2003 206
2004 235
2005 262
2006 275
2007 339
2008 428
2009 449
2010 602
2011 638
2012 734
2013 734
2014 791
2015 804
2016 790
2017 788
2018 777
2019 806
2020 762
2021 813
2022 389
Text availability
Article attribute
Article type
Publication date

Search Results

11,124 results
Results by year
Filters applied: . Clear all
Page 1
Cutaneous T cell lymphoma.
Dummer R, Vermeer MH, Scarisbrick JJ, Kim YH, Stonesifer C, Tensen CP, Geskin LJ, Quaglino P, Ramelyte E. Dummer R, et al. Among authors: kim yh. Nat Rev Dis Primers. 2021 Aug 26;7(1):61. doi: 10.1038/s41572-021-00296-9. Nat Rev Dis Primers. 2021. PMID: 34446710 Review.
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data.
Horwitz SM, Scarisbrick JJ, Dummer R, Whittaker S, Duvic M, Kim YH, Quaglino P, Zinzani PL, Bechter O, Eradat H, Pinter-Brown L, Akilov OE, Geskin L, Sanches JA, Ortiz-Romero PL, Weichenthal M, Fisher DC, Walewski J, Trotman J, Taylor K, Dalle S, Stadler R, Lisano J, Bunn V, Little M, Prince HM. Horwitz SM, et al. Among authors: kim yh. Blood Adv. 2021 Dec 14;5(23):5098-5106. doi: 10.1182/bloodadvances.2021004710. Blood Adv. 2021. PMID: 34507350 Free PMC article. Clinical Trial.
Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma.
Phillips D, Matusiak M, Gutierrez BR, Bhate SS, Barlow GL, Jiang S, Demeter J, Smythe KS, Pierce RH, Fling SP, Ramchurren N, Cheever MA, Goltsev Y, West RB, Khodadoust MS, Kim YH, Schürch CM, Nolan GP. Phillips D, et al. Among authors: kim yh. Nat Commun. 2021 Nov 18;12(1):6726. doi: 10.1038/s41467-021-26974-6. Nat Commun. 2021. PMID: 34795254 Free PMC article. Clinical Trial.
Primary Cutaneous Lymphoma: Recommendations for Clinical Trial Design and Staging Update from the ISCL, USCLC, and EORTC.
Olsen EA, Whittaker S, Willemze R, Pinter-Brown L, Foss FM, Geskin LJ, Schwartz LH, Horwitz SM, Guitart J, Zic J, Kim YH, Wood GS, Duvic M, Ai WZ, Girardi M, Gru A, Guenova E, Hodak E, Hoppe RT, Kempf W, Kim EJ, Lechowicz MJ, Ortiz-Romero PL, Papadavid E, Quaglino P, Pittelkow MR, Prince HM, Sanches JA, Sugaya M, Vermeer MH, Zain J, Knobler R, Stadler R, Bagot M, Scarisbrick JJ. Olsen EA, et al. Among authors: kim yh. Blood. 2021 Nov 10:blood.2021012057. doi: 10.1182/blood.2021012057. Online ahead of print. Blood. 2021. PMID: 34758074
Robot-assisted Kidney Transplantation.
Lim SJ, Ko Y, Kim DH, Jung JH, Kwon H, Kim YH, Shin S. Lim SJ, et al. Among authors: kim yh. J Vis Exp. 2021 Jul 19;(173). doi: 10.3791/62220. J Vis Exp. 2021. PMID: 34338681
Targeted theranostic photoactivation on atherosclerosis.
Song JW, Ahn JW, Lee MW, Kim HJ, Kang DO, Kim RH, Kang UG, Kim YH, Han J, Park YH, Nam HS, Yoo H, Park K, Kim JW. Song JW, et al. Among authors: kim yh. J Nanobiotechnology. 2021 Oct 24;19(1):338. doi: 10.1186/s12951-021-01084-z. J Nanobiotechnology. 2021. PMID: 34689768 Free PMC article.
Synthesis and Application of Silica-Coated Quantum Dots in Biomedicine.
Pham XH, Park SM, Ham KM, Kyeong S, Son BS, Kim J, Hahm E, Kim YH, Bock S, Kim W, Jung S, Oh S, Lee SH, Hwang DW, Jun BH. Pham XH, et al. Among authors: kim yh. Int J Mol Sci. 2021 Sep 18;22(18):10116. doi: 10.3390/ijms221810116. Int J Mol Sci. 2021. PMID: 34576279 Free PMC article. Review.
11,124 results
You have reached the last available page of results. Please see the User Guide for more information.